Scarica l'app Stockscreener
6.47
0.31%
-0.03
Day One Biopharmaceuticals Inc Borsa (DAWN) Ultime notizie
Day One Biopharmaceuticals Inc. Stock Analysis and ForecastFree Stock Chart Pattern Guide - Jammu Links News
What drives Day One Biopharmaceuticals Inc. stock priceExceptional gains - Jammu Links News
How Day One Biopharmaceuticals Inc. stock performs during market volatilityFree Access to Community - Newser
Why Day One Biopharmaceuticals Inc. stock attracts strong analyst attentionTop Performing Low Risk Stocks - Newser
What makes Day One Biopharmaceuticals Inc. stock price move sharplyCapital Growth Picks - Newser
When the Price of (DAWN) Talks, People Listen - news.stocktradersdaily.com
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Average Recommendation of “Buy” by Brokerages - Defense World
Wealth Enhancement Advisory Services LLC Makes New $88,000 Investment in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World
Day One Announces Pricing of Upsized Initial Public Offering - IT Business Net
Day One Biopharmaceuticals, Inc. shares rise 4.16% intraday after positive mid-term outlook from Lonza Group. - AInvest
DAY ONE BIOPHARMACEUTICALS Earnings Preview: Recent $DAWN Insider Trading, Hedge Fund Activity, and More - Nasdaq
AMPY Stock: A Voyage Through Amplify Energy Corp’s Finances - investchronicle.com
(DAWN) On The My Stocks Page - news.stocktradersdaily.com
When Will Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Breakeven? - Yahoo Finance
TimesSquare Capital U.S. Small Cap Growth Strategy Exited its Position in Day One Biopharmaceuticals Inc. (DAWN) - MSN
Day 8 of Loss Streak for Day One Biopharmaceuticals Stock with -11% Return (vs. -49% YTD) [6/18/2025] - Trefis
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Average Rating of “Buy” by Brokerages - Defense World
Pallas Capital Advisors LLC Takes Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World
Bank of America Corp DE Has $260,000 Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World
Where are the Opportunities in (DAWN) - news.stocktradersdaily.com
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Transcript : Day One Biopharmaceuticals, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 08 - MarketScreener
Day One Appoints Michael Vasconcelles As Head Of Research And Development - MarketScreener
Day One Biopharmaceuticals (DAWN) Welcomes New R&D Leader | DAWN Stock News - GuruFocus
Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development - GlobeNewswire
Day One Taps ImmunoGen Executive to Lead R&D: 25-Year Oncology Expert Joins Cancer Drug Developer - Stock Titan
H.C. Wainwright Maintains Buy Rating on Day One Biopharmaceuticals (DAWN), Keeps PT - MSN
Ameriprise Financial Inc. Decreases Holdings in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World
Squarepoint Ops LLC Acquires New Holdings in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World
JonesTrading Maintains Buy Rating on Day One Biopharmaceuticals (DAWN) Following Ojemda’s FDA Approval - Insider Monkey
Day One Biopharmaceuticals: Strong Ojemda Potential In Q2 And Solid Rationale For DAY-301 - Seeking Alpha
Nuveen Asset Management LLC Lowers Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Bought by Millennium Management LLC - Defense World
ProShare Advisors LLC Increases Stock Holdings in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Acquires 1,894 Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World
Cetera Investment Advisers Has $400,000 Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World
36,685 Shares in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Bought by BNP Paribas Financial Markets - Defense World
D. E. Shaw & Co. Inc. Increases Stock Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Receives Consensus Rating of “Buy” from Brokerages - Defense World
We Think Day One Biopharmaceuticals (NASDAQ:DAWN) Can Afford To Drive Business Growth - Yahoo Finance
Northern Trust Corp Grows Holdings in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World
Day one Biopharmaceuticals officer sells $24,574 in stock By Investing.com - Investing.com Nigeria
Day one Biopharmaceuticals officer sells $24,574 in stock - Investing.com
Day One Biopharmaceuticals Executives Sell Shares to Cover Tax Liabilities - TradingView
Day one biopharmaceuticals highlights OJEMDA revenue growth and pipeline progress in Q1 2025 - MSN
Day One Biopharmaceuticals Insider Lowered Holding By 20% During Last Year - simplywall.st
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Stake Decreased by Voya Investment Management LLC - Defense World
Transcript : Day One Biopharmaceuticals, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 08 - marketscreener.com
Is Day One Biopharmaceuticals, Inc. (DAWN) the Best Low Priced Biotech Stock to Buy Now? - MSN
0.86%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):